Satisfaction of Patients With Erectile Dysfunction With the Use of Sildenafil Oral Suspension Compared to Orodispersible Tablets

The goal of this observational retrospective study is to to evaluate treatment satisfaction with sildenafil oral suspension in patients with mild-to-moderate ED who were previously taking orodispersible sildenafil. The secondary objective is to evaluate the efficacy and side effects of therapy with sildenafil oral suspension compared to orodispersible sildenafil. Patients who took sildenafil orodispersible 50 mg for 3 months and subsequently took sildenafil oral suspension for another 3 months will be enrolled.

Inclusion Criteria: * Age 18-75 * Male * Sexually active (at least 2 sexual encounters per week) * IIEF-EF between 11 and 25 at baseline Exclusion Criteria: * hypogonadism (total testosterone \< 3.5 ng/mL) * previous pelvic surgery * ED on a neurogenic basis * concomitant use of other ED therapies * conical therapy with nitrates or other contraindicated drugs in combination with sildenafil * hypersensitivity to the active ingredient * patients for whom sexual activity is not recommended (e.g. patients with serious cardiovascular disorders, such as unstable angina or severe heart failure). * patients who have lost vision in one eye due to non-arteritic anterior ischemic optic neuropathy (NAION), whether or not this event was related to previous use of a phosphodiesterase type 5 (PDE5) inhibitor * patients with severe hepatic impairment, hypotension (blood pressure \